Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ)
CNY 12.67
(-7.45%)
CNY 12.67
(-7.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 227.7 Million | -37.2 Million | 50.52 Million | 395.85 Million | 223.32 Million | 114.26 Million |
| Net Income | 17.76 Million | -56.24 Million | 39.43 Million | 223.09 Million | 93.48 Million | 61.69 Million |
| Depreciation & Amortization | 56.83 Million | 61.25 Million | 49.42 Million | 39.24 Million | 32.17 Million | 29.56 Million |
| Deferred income taxes | -1.87 Million | -6.11 Million | 3.82 Million | -3.6 Million | 31.7 Thousand | 1.59 Million |
| Stock-based compensation | - | - | - | 396.75 Thousand | 14.06 Million | 1.18 Million |
| Change in working capital | 129.99 Million | -110.74 Million | -53.77 Million | 67.27 Million | 74.75 Million | 16.72 Million |
| Other non-cash items | -1.34 Million | 68.54 Million | 15.43 Million | 66.24 Million | 22.91 Million | 6.28 Million |
| Investing Cash Flow | -73.24 Million | -112.13 Million | -114.91 Million | -311.47 Million | -135.71 Million | -90.18 Million |
| Investments in PPE | -66 Million | -116.39 Million | -240.44 Million | -220.7 Million | -125.86 Million | -89.77 Million |
| Acquisitions | 785.25 Thousand | 605.65 Thousand | 24.96 Million | 121.09 Thousand | 267.86 Thousand | 1080.00 |
| Investment purchases | -10.56 Million | -65 Million | -95 Million | -150.25 Million | -88 Million | -17 Million |
| Sales/Maturities of investments | - | 65.23 Million | 220.06 Million | 51.1 Million | 68.56 Million | 17.02 Million |
| Other Investing Activities | 2.63 Million | 3.41 Million | -24.49 Million | 8.25 Million | 9.31 Million | -436.91 Thousand |
| Financing Cash Flow | 396.75 Thousand | -49.87 Million | 683.82 Million | 28.46 Million | -137.66 Million | -40.52 Million |
| Debt repayment | -3.05 Million | -840 Thousand | -149.1 Million | -80.6 Million | -11 Million | -25 Million |
| Dividends payments | - | -19.03 Million | -882.68 Thousand | -23.63 Million | -180.47 Million | -1.52 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.65 Million | -30.84 Million | 833.8 Million | 132.69 Million | 53.81 Million | -14 Million |
| Accounts receivables | 55.59 Million | -30.95 Million | 114.13 Million | -101.19 Million | -22.64 Million | -13.58 Million |
| Accounts payables | 18.38 Million | -33.45 Million | -137.68 Million | 167.6 Million | 117.99 Million | 20.27 Million |
| Inventory | 57.88 Million | -40.22 Million | -34.04 Million | 4.46 Million | -20.62 Million | 8.43 Million |
| Other working capital | 16.5 Million | -6.11 Million | 3.82 Million | -3.59 Million | 31.65 Thousand | 8.29 Million |
| Cash at beginning of period | 639.45 Million | 834.42 Million | 217.64 Million | 116.43 Million | 164.84 Million | 180.51 Million |
| Cash at end of period | 796.44 Million | 639.45 Million | 834.42 Million | 217.64 Million | 116.43 Million | 164.84 Million |
| Capital Expenditure | -66 Million | -116.39 Million | -240.44 Million | -220.7 Million | -125.86 Million | -89.77 Million |
| Effect of forex changes on cash | 2.13 Million | 4.24 Million | -2.64 Million | -11.64 Million | 1.64 Million | 779.65 Thousand |
| Net cash flow / Change in cash | 156.98 Million | -194.96 Million | 616.78 Million | 101.2 Million | -48.41 Million | -15.66 Million |
| Free Cash Flow | 161.69 Million | -153.6 Million | -189.92 Million | 175.14 Million | 97.46 Million | 24.48 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.14 Million | 4.88 Million | 18.33 Million | -7.01 Million | 17.76 Million | 5.31 Million |
| Depreciation & Amortization | - | 15.52 Million | - | 56.83 Million | 56.83 Million | -27.93 Million |
| Deferred income taxes | - | - | - | - | -1.87 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 7.54 Million | - | 113.48 Million | 129.99 Million | -91.66 Million |
| Other non-cash items | 24.27 Million | 12.96 Million | -4.6 Million | -97.51 Million | -1.34 Million | 176.63 Million |
| Investing Cash Flow | 999.64 Thousand | -224.76 Million | -23.92 Million | -10.66 Million | -73.24 Million | -20.04 Million |
| Investments in PPE | -20.22 Million | -16.16 Million | -28.52 Million | -12.78 Million | -66 Million | -14.27 Million |
| Acquisitions | - | 1.4 Million | 4.8 Million | 563.18 Thousand | 785.25 Thousand | -2.89 Million |
| Investment purchases | -533.04 Million | -210 Million | - | - | -10.56 Million | -3.96 Million |
| Sales/Maturities of investments | 553.04 Million | - | - | - | - | 2.89 Million |
| Other Investing Activities | 554.27 Million | -208.6 Million | 4.6 Million | 1.65 Million | 2.63 Million | -1.81 Million |
| Financing Cash Flow | -20.6 Million | -1.64 Million | -31.15 Million | 10.11 Million | 396.75 Thousand | 1.97 Million |
| Debt repayment | -450 Thousand | - | - | -3.05 Million | -3.05 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 30.09 Million | -30.09 Million | - | -100 Thousand | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -20.6 Million | 30.9 Million | -31.15 Million | 7.06 Million | -2.65 Million | 1.97 Million |
| Accounts receivables | - | 15.28 Million | - | 55.59 Million | 55.59 Million | -31.08 Million |
| Accounts payables | - | - | - | - | 18.38 Million | - |
| Inventory | - | -7.74 Million | - | 57.88 Million | 57.88 Million | -60.58 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 533.5 Million | 822.31 Million | 796.44 Million | 731.73 Million | 639.45 Million | 687.06 Million |
| Cash at end of period | 531.13 Million | 593.83 Million | 756.8 Million | 796.44 Million | 796.44 Million | 731.73 Million |
| Capital Expenditure | -20.22 Million | -16.16 Million | -28.52 Million | -12.78 Million | -66 Million | -14.27 Million |
| Effect of forex changes on cash | -4.67 Million | 789.68 Thousand | 1.72 Million | -525.93 Thousand | 2.13 Million | 378.38 Thousand |
| Net cash flow / Change in cash | -2.37 Million | -228.48 Million | -39.63 Million | 64.7 Million | 156.98 Million | 44.66 Million |
| Free Cash Flow | 2.91 Million | -13.84 Million | -14.79 Million | 53 Million | 161.69 Million | 48.08 Million |
1711
KLPEF
RENX
HSS
ICHI
1651